Investing in 4.0 Makes Both Technological and Financial Sense
Pharma 4.0 looks to be a total strategic move as biopharmaceutical manufacturing plants become ecosystems of intensified, connected operations.
Pharma 4.0 looks to be a total strategic move as biopharmaceutical manufacturing plants become ecosystems of intensified, connected operations.
Addition of B. subtilis spores also pushed mechanical properties of plastic beyond known limitations, addressing trade off between tensile strength and stretchability
Lonza says its Route Scouting Service helps chemistry, manufacturing and control teams overcome the challenge of rising API complexity.
Researchers at the Karolinska Institute may have found a new way to treat obesity and related disorders by targeting the mitochondria. Their findings in mice…
CNS drug developers should prioritize the discovery of novel biomarkers through objective testing methods that go beyond genetics, says Linus Bio CEO Manish Arora, PhD.
Addition of B. subtilis spores also pushed mechanical properties of plastic beyond known limitations, addressing trade off between tensile strength and stretchability
Genetically depleting AC3-AT protected mice from obesity as they were better able to burn calories and increased their metabolic rates through activating brown fat.
Prime Medicine said it has gained FDA clearance for the first human trials of a prime editing therapy as the agency has approved an investigational…
Addition of B. subtilis spores also pushed mechanical properties of plastic beyond known limitations, addressing trade off between tensile strength and stretchability
Researchers have discovered a new so-called lantibiotic, called epilancin A37.
An engineered increase in mesophyll conductance, by reducing the thickness of cell walls, results in improved photosynthetic efficiency.